FITZPATRICK STEVEN R 4

Accession 0001225208-11-008166

CIK 0001170650other

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:44 PM ET

Size

51.3 KB

Accession

0001225208-11-008166

Insider Transaction Report

Form 4

Period: 2011-02-28

MEDCO HEALTH SOLUTIONS INCMHS

FITZPATRICK STEVEN R

Pres, Accredo Health, Inc.

Transactions

Exercise/Conversion
Stock Option
2011-02-28−3,550→ 23,950 total
Exercise: $28.17Exp: 2016-02-23→ Common Stock (3,550 underlying)
Exercise/Conversion
Stock Option
2011-02-28−23,433→ 16,567 total
Exercise: $25.80Exp: 2016-04-30→ Common Stock (23,433 underlying)
Exercise/Conversion
Stock Option
2011-03-01−16,567→ 0 total
Exercise: $25.80Exp: 2016-04-30→ Common Stock (16,567 underlying)
Exercise/Conversion
Common Stock
2011-02-28$33.70/sh+22,020$742,074→ 148,960.463 total
Exercise/Conversion
Common Stock
2011-02-28$27.19/sh+14,712$400,019→ 179,494.463 total
Exercise/Conversion
Common Stock
2011-02-28$28.17/sh+3,550$100,004→ 198,837.463 total
Sale
Common Stock
2011-02-28$62.41/sh−6,673$416,462→ 192,164.463 total
Sale
Common Stock
2011-02-28$62.03/sh−9,120$565,714→ 183,044.463 total
Sale
Common Stock
2011-02-28$62.04/sh−23,446$1,454,590→ 98,323.463 total
Exercise/Conversion
Stock Option
2011-02-28−22,020→ 0 total
Exercise: $33.70Exp: 2017-02-22→ Common Stock (22,020 underlying)
Exercise/Conversion
Stock Option
2011-02-28−15,822→ 0 total
Exercise: $27.19Exp: 2015-09-15→ Common Stock (15,822 underlying)
Exercise/Conversion
Common Stock
2011-02-28$40.58/sh+6,673$270,790→ 195,287.463 total
Sale
Common Stock
2011-02-28$62.03/sh−15,822$981,439→ 167,222.463 total
Sale
Common Stock
2011-02-28$62.04/sh−22,020$1,366,121→ 145,202.463 total
Sale
Common Stock
2011-03-01$62.29/sh−504$31,394→ 114,890.463 total
Exercise/Conversion
Stock Option
2011-02-28−9,120→ 4,560 total
Exercise: $50.35Exp: 2018-02-21→ Common Stock (9,120 underlying)
Exercise/Conversion
Common Stock
2011-02-28$28.17/sh+23,446$660,474→ 103,507.463 total
Exercise/Conversion
Stock Option
2011-02-28−23,446→ 504 total
Exercise: $28.17Exp: 2016-02-23→ Common Stock (23,446 underlying)
Exercise/Conversion
Stock Option
2011-02-28−14,712→ 15,822 total
Exercise: $27.19Exp: 2015-09-15→ Common Stock (14,712 underlying)
Exercise/Conversion
Common Stock
2011-02-28$25.80/sh+23,433$604,571→ 126,940.463 total
Exercise/Conversion
Common Stock
2011-02-28$27.19/sh+15,822$430,200→ 164,782.463 total
Exercise/Conversion
Common Stock
2011-02-28$50.35/sh+9,120$459,192→ 188,614.463 total
Sale
Common Stock
2011-02-28$62.04/sh−23,433$1,453,783→ 121,769.463 total
Exercise/Conversion
Common Stock
2011-03-01$25.80/sh+16,567$427,429→ 114,890.463 total
Exercise/Conversion
Common Stock
2011-03-01$28.17/sh+504$14,198→ 115,394.463 total
Sale
Common Stock
2011-03-01$62.08/sh−16,567$1,028,479→ 98,323.463 total
Exercise/Conversion
Stock Option
2011-02-28−6,673→ 13,347 total
Exercise: $40.58Exp: 2019-02-26→ Common Stock (6,673 underlying)
Exercise/Conversion
Stock Option
2011-03-01−504→ 0 total
Exercise: $28.17Exp: 2016-02-23→ Common Stock (504 underlying)

Footnotes (14)

[F1]Sale pursuant to 10b5-1 Trading Plan.
[F10]This option vests and becomes exercisable in three annual installments beginning on February 23, 2008, subject to continued employment.
[F11]This option vests and becomes exercisable in three annual installments beginning February 24, 2007, subject to continued employment.
[F12]This option vests and becomes exercisable in three annual installments beginning February 27, 2010, subject to continued employment.
[F13]This option vests and becomes exercisable in three annual installments beginning May 1, 2007, subject to continued employment.
[F14]This option vests and becomes exercisable in three annual installments beginning September 16, 2006, subject to continued employment.
[F2]Represents weighted average sale price. Sales were executed at prices that ranged from $62.13 to $62.67.
[F3]Represents weighted average sale price. Sales were executed at prices that ranged from $62.00 to $62.21.
[F4]Represents weighted average sale price. Sales were executed at prices that ranged from $62.00 to $62.13.
[F5]Represents weighted average sale price. Sales were executed at prices that ranged from $62.00 to $62.11.
[F6]Represents weighted average sale price. Sales were executed at prices that ranged from $62.00 to $62.16.
[F7]Represents weighted average sale price. Sales were executed at prices that ranged from $62.03 to $62.24.
[F8]Exercise pursuant to 10b5-1 Trading Plan.
[F9]This option vests and becomes exercisable in three annual installments beginning February 22, 2009, subject to continued employment.

Documents

1 file

4
doc4.xmlPrimary

Issuer

MEDCO HEALTH SOLUTIONS INC

CIK 0001170650

→

Entity typeother

Related Parties

filerCIK 0001253877

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 4:44 PM ET
Size: 51.3 KB

View on SEC.gov